"Scientists in the UK are testing the efficacy and safety of a vaccine that acts in a similar way to the body's own natural immune responses against bacterial and viral infections."
This trial aims to enable the immune system of patients with solid tumors to fight advanced cancer. The investigation will last approximately two years. It is intended to establish the benefits of vaccination, the secondary effects that may appear and the impact of the treatment on the quality of life of the patients who participate in it. The scientists hope that the results they obtain will help promote the development of an effective, but non-toxic, cancer therapy.